Pillstats
Rx only · Tablet · Oral

Pimozide

Pimozide

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN05AG02
RxCUI (US)8331
US makers2 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.427$0.853$1.28$1.71Dec 2025Apr 2026Jul 2026
$1.472
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8651.7K2.6K3.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.6K
Rx · 2026 Q1
183K
Units dispensed
-15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Endo USA, Inc.unknown2SUPPLYING
ANI Pharmaceuticals, Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.